2006 consensus guidelines for the management of women with abnormal cervical screening tests.
about
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.A population-based evaluation of cervical screening in the United States: 2008-2011.Cervical excisional treatment of young women: a population-based studyThe accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials.Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort StudyA study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United StatesImpact of improved classification on the association of human papillomavirus with cervical precancer.Loop Electrosurgical Excisional Procedure (LEEP) Done for Discrepancy: Does the Time from HGSIL Affect Pathologic Grade of CIN in LEEP Specimen?Update on prevention and screening of cervical cancer.Detection of cervical intraepithelial neoplasias and cancers in cervical tissue by in vivo light scattering.Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesionsManagement of borderline change in endocervical cells: a more dependable approachUpdated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, SpainDetection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.Informatics methods for laboratory evaluation of HPV ordering patterns with an example from a nationwide sample in the United States, 2003-2009.Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology SpecimensHistologic correlates of glandular abnormalities in cervical cytology among women with human immunodeficiency virus.Significance of HPV-58 infection in women who are HPV-positive, cytology-negative and living in a country with a high prevalence of HPV-58 infection.Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment.The challenge of follow-up in a low-income colposcopy clinic: characteristics associated with noncompliance in high-risk populations.PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the TOMBOLA randomised controlled trialClinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimensEvaluation of a new DNA test for detection of carcinogenic human papillomavirus.Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.Prevalence of human papillomavirus infection in women in Benin, West Africa.Comparative performance of human papillomavirus DNA testing using novel sample collection methods.Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium.Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer.The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women.Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection ProgramCervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007.Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management.A prospective randomized study on limits of colposcopy and histology: the skill of colposcopist and colposcopy-guided biopsy in diagnosis of cervical intraepithelial lesionsLaboratory and clinical aspects of human papillomavirus testing
P2860
Q24607403-F36A1381-8BE3-4829-9B96-97DDCC7347FEQ26828840-96A00C69-A389-4C58-9971-39164AD709B8Q30405438-747BAA14-7E59-4D8E-B6EB-6BB10A04BAFBQ30407712-84FA78CB-C062-46D4-AF78-CB41EE8F8762Q30450948-F9BDDD9D-CC64-4F7A-AE0F-C591E3BA2C1EQ33444450-FF6F309E-5618-4D43-AEFD-1D65269471C5Q33580897-59DFDEC4-F4EF-4D97-BEE3-A36ADFB51216Q33841259-3BD23E55-30D4-4075-9FFE-95E93D6E3B40Q33883581-F60B2E84-37B5-4327-B763-5D717BC7F6D6Q34022027-18B81513-7A08-4DCF-BEFF-0A008880C0DBQ34031269-6F07FDBE-184D-4EAC-B340-3C79D2400609Q34043421-E9FD7DBF-1772-44BD-BBD3-532870389A92Q34055574-448B0FD2-43E0-40D0-A954-DDB06E874867Q34113493-071F1EE2-7565-4461-BC31-5BA4BEB57827Q34121746-5C3A0777-0C77-4C10-B0B6-3806B49FE7CCQ34141990-9F69183E-5A18-4EF3-88FF-FC94E4632BF5Q34239710-D87E10A5-0243-41AC-9A1E-A34AD8D09130Q34442449-D00D2BBA-BF8D-4E89-ADF4-8720257717B3Q34533374-C31ECF7F-3DA8-4230-B169-62250D161F34Q34546669-FA36C8CA-9183-49E9-A2AD-F6DDD761F886Q34625983-CED9ED7E-64F2-4038-894D-61AC14017E95Q34636306-7B16E71F-4044-4F13-B234-632F7334E0A1Q34940816-6F8747D4-2F31-42A0-B5D2-B92640BC41ABQ35000542-06A0D2B8-6486-4B0F-8373-61181043772EQ35051454-CCBEBA3E-407F-4CF4-9762-A5CC370503F7Q35079942-0F068B0A-E28B-44C8-9859-EAA92C06DC09Q35083587-87ECC445-110A-4432-8516-283F63811BABQ35139772-D44E6C0E-8362-44A8-B813-C04C28FA2BD0Q35203306-DF370D90-1E65-429D-BC14-FD45CE4D6B65Q35588255-E9F13E43-5C8E-4F7E-B83A-439FCA8B7E0CQ35596164-F4830D16-6ABD-4EAB-B1E8-E3AAA9F3863DQ35598854-D0BC461E-0FC6-4561-BEF1-815787FD56C7Q35668217-B5BB46C6-3712-40EE-8838-80BDD14A2D4EQ35689055-9391FD37-A4FA-40B6-B380-1F0F449154C6Q35809257-F77D5639-CB1E-4E93-8A4C-21E957587F1CQ35985039-5D95BD60-B3AC-4E79-BF3A-47DD1D455CE5Q35985606-C6CF6FB0-2A5C-40C9-A4FD-E623D7291EF9Q36133449-D7868459-2601-4023-9E95-9159454DE803Q36301978-122293A0-B978-416D-BD38-D0C588CB2ABDQ36311573-EC2D7842-FD05-446B-A1AF-95FCC235A242
P2860
2006 consensus guidelines for the management of women with abnormal cervical screening tests.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
2006 consensus guidelines for ...... rmal cervical screening tests.
@en
type
label
2006 consensus guidelines for ...... rmal cervical screening tests.
@en
prefLabel
2006 consensus guidelines for ...... rmal cervical screening tests.
@en
P2093
P1476
2006 consensus guidelines for ...... rmal cervical screening tests.
@en
P2093
2006 ASCCP-Sponsored Consensus Conference
Charles J Dunton
Diane Solomon
Edward J Wilkinson
L Stewart Massad
Mark Spitzer
Thomas C Wright
P304
P356
10.1097/LGT.0B013E3181585870
P577
2007-10-01T00:00:00Z